BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 25378988)

  • 1. Fibromuscular dysplasia: a cause of secondary hypertension.
    Shejul YK; Viswanathan MK; Jangale P; Kulkarni A
    Korean J Intern Med; 2014 Nov; 29(6):840-1. PubMed ID: 25378988
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal artery stent fracture in patients with fibromuscular dysplasia: a cautionary tale.
    Raju MG; Bajzer CT; Clair DG; Kim ES; Gornik HL
    Circ Cardiovasc Interv; 2013 Jun; 6(3):e30-1. PubMed ID: 23780296
    [No Abstract]   [Full Text] [Related]  

  • 3. Rational decision making in the treatment of renal artery stenosis.
    Mitterbauer C; Oberbauer R
    Wien Klin Wochenschr; 2002 Jan; 114(1-2):1-3. PubMed ID: 12407927
    [No Abstract]   [Full Text] [Related]  

  • 4. Misconceptions about the diagnosis and treatment of fibromuscular dysplasia.
    Olin JW
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):265-6. PubMed ID: 19642172
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic hypertension and transient ischemic attack in a 6-year-old girl with fibromuscular dysplasia treated with percutaneous angioplasty.
    Foa-Torres G; Ganame J; Juaneda E; Peirone A; Barcudi MS; Achaval A
    Cardiovasc Intervent Radiol; 2010 Feb; 33(1):173-6. PubMed ID: 19367433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal infarction complicating fibromuscular dysplasia.
    Gavalas M; Meisner R; Labropoulos N; Gasparis A; Tassiopoulos A
    Vasc Endovascular Surg; 2014; 48(7-8):445-51. PubMed ID: 25227972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short- and long-term outcomes of percutaneous transluminal angioplasty/stenting of renal fibromuscular dysplasia over a ten-year period.
    Mousa AY; Campbell JE; Stone PA; Broce M; Bates MC; AbuRahma AF
    J Vasc Surg; 2012 Feb; 55(2):421-7. PubMed ID: 22112553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights from intravascular pressure measurement of renal artery revascularization in patients with fibromuscular dysplasia: The DYSART study.
    Cadour F; Silhol F; Iline N; Giorgi R; Lorthioir A; Amar L; Sapoval M; Rousseau H; Sarlon G; Thony F; Jacquier A
    J Vasc Surg; 2022 Mar; 75(3):939-949.e1. PubMed ID: 34601043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arterial hypertension of rapid onset].
    Rioux D
    Union Med Can; 1992; 121(6):376-9. PubMed ID: 1481299
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of Renovascular Hypertension.
    Smith A; Gaba RC; Bui JT; Minocha J
    Tech Vasc Interv Radiol; 2016 Sep; 19(3):211-7. PubMed ID: 27641455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of stent failure in a patient with fibromuscular dysplasia following renal artery stenting.
    Wang LC; Scott DJ; Clemens MS; Hislop SJ; Arthurs ZM
    Ann Vasc Surg; 2015 Jan; 29(1):123.e19-21. PubMed ID: 25192822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. When ballooning alone is enough: successful treatment of hypertension secondary to renal artery fibromuscular dysplasia using angioplasty.
    Yong AS; Wyndham R; Lowe HC
    Int J Cardiol; 2009 Jan; 131(3):e85-6. PubMed ID: 17945366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of renal artery fibromuscular dysplasia: angiography, intravascular ultrasound (with virtual histology), and pressure wire measurements.
    Prasad A; Zafar N; Mahmud E
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):260-4. PubMed ID: 19213069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes Following the Endovascular Treatment of Renal Artery Stenosis Caused by Fibromuscular Dysplasia: A Systematic Review and Meta-Analysis.
    Tian Y; Yuan B; Zhang N; Huang Z
    Ann Vasc Surg; 2022 Jan; 78():362-372. PubMed ID: 34543714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal artery stenosis and ambulatory blood pressure monitoring: A case report and review of the literature.
    Reeves RR; Walters D; Mahmud E
    Catheter Cardiovasc Interv; 2018 Mar; 91(4):760-764. PubMed ID: 29068131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renovascular Hypertension.
    Herrmann SM; Textor SC
    Endocrinol Metab Clin North Am; 2019 Dec; 48(4):765-778. PubMed ID: 31655775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and treatment of renal artery fibromuscular dysplasia with percutaneous transluminal angioplasty: a long-term follow-up study.
    Yang YK; Zhang Y; Meng X; Yang KQ; Jiang XJ; Wu HY; Zhang HM; Song L; Wang LP; Gao LG; Zhou XL
    Clin Res Cardiol; 2016 Nov; 105(11):930-937. PubMed ID: 27270759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orthostatic hypertension due to coexistence of renal fibromuscular dysplasia and nephroptosis.
    Tsukamoto Y; Komuro Y; Akutsu F; Fujii K; Marumo F; Kusano S; Kikawada R
    Jpn Circ J; 1988 Dec; 52(12):1408-14. PubMed ID: 2977192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Segmental arterial mediolysis: angioplasty of bilateral renal artery stenoses with 2-year imaging follow-up.
    Soulen MC; Cohen DL; Itkin M; Townsend RR; Roberts DA
    J Vasc Interv Radiol; 2004 Jul; 15(7):763-7. PubMed ID: 15231892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful stenting of bilateral renal artery stenosis due to fibromuscular dysplasia assessed by use of pressure guidewire technique: a case report.
    Imamura H; Isobe M; Takenaka H; Kinoshita O; Sekiguchi M; Ohta M
    Angiology; 1998 Jan; 49(1):69-74. PubMed ID: 9456167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.